Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Colorectal Cancer Clinical Trial
ASPirin Intervention for the REDuction of Colorectal Cancer Risk
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
UW Cancer Center at ProHealth Care
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC
Status: Enrolling, Phase I, II
Updated: 1/17/2018
Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Texas Oncology-Abilene
mi
from
Abilene, TX
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Baptist Health Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Cancer Institute
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Greer
mi
from
Greer, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Doctor's Hospital of Laredo
mi
from
Laredo, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Seneca
mi
from
Seneca, SC
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma
Status: Enrolling, Phase II
Updated: 3/28/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Status: Enrolling, Phase I, II
Updated: 2/7/2018
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Status: Enrolling, Phase I, II
Updated: 2/7/2018
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
Status: Enrolling, Phase I, II
Updated: 2/7/2018
University of Virginia Cancer Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Harrison Medical Center
mi
from
Bremerton, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Pacific Gynecology Specialists
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hickman Cancer Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Summa Akron City Hospital/Cooper Cancer Center
mi
from
Akron, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Alaska Oncology and Hematology LLC
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Anchorage Oncology Centre
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Anchorage Radiation Therapy Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Deer Valley Medical Center
mi
from
Antioch, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
MultiCare Auburn Medical Center
mi
from
Auburn, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Eastern Maine Medical Center
mi
from
Bangor, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Mary Bird Perkins Cancer Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Bronson Battle Creek
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Swedish Cancer Institute-Eastside Oncology Hematology
mi
from
Bellevue, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Beverly Hospital
mi
from
Beverly, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Parkland Health Center-Bonne Terre
mi
from
Bonne Terre, MO
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
California Cancer Associates for Research and Excellence
mi
from
Fresno, CA
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
Illinois Cancercare, Pc
mi
from
Peoria, IL
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
Pacific Hematology Oncology Associates (PHOA)
mi
from
San Francisco, CA
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization
Status: Enrolling
Updated: 6/15/2016
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver
Status: Enrolling, Phase
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Blood Samples to Identify Biomarkers of Busulfan
Status: Enrolling, Phase
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Status: Enrolling, Phase I
Updated: 7/28/2015
Baltimore Clinical Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Status: Enrolling, Phase I
Updated: 7/28/2015
Boston Clinical Site
mi
from
Boston, MA
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Status: Enrolling, Phase I
Updated: 12/31/1969
Baltimore Clinical Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling, Phase
Updated: 12/31/1969
University of Kansas Cancer Center
mi
from
Westwood, KS
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable Metastatic Pheochromocytomas and Paragangliomas
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 8/31/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroesophageal Cancer Clinical Trial
Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Status: Enrolling, Phase II
Updated: 12/14/2017
Rocky Mountain Cancer Centers
mi
from
Denver, CO
Click here to add this to my saved trials
Sarcoma Clinical Trial
NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy
Status: Enrolling, Phase I
Updated: 6/27/2016
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer
Status: Enrolling, Phase I
Updated: 5/5/2016
University of Florida College of Med
mi
from
Gainesville, FL
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer
Status: Enrolling, Phase I
Updated: 5/5/2016
Greenville Hospital System
mi
from
Greenville, SC
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer
Status: Enrolling, Phase I
Updated: 5/5/2016
University of Utah, Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
MK-3475/BCG in High Risk Superficial Bladder Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Simmons Cancer Institute at SIU School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
Status: Enrolling
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Inovio TRT-001: Telomerase DNA Immunotherapy in Breast, Lung, and Pancreatic Cancers
Status: Enrolling, Phase I
Updated: 8/3/2016
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
ColoCare Study - Colorectal Cancer Cohort
Status: Enrolling
Updated: 11/30/2017
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy
Status: Enrolling
Updated: 5/10/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Tech University Health Sciences Center School of Medicine
mi
from
Amarillo, TX
Click here to add this to my saved trials
Solid Tumors Clinical Trial
A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigational Chemotherapy Service
mi
from
Durham, NC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California, San Diego (UCSD)
mi
from
La Jolla, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Stony Brook Medicine
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of BGB324 in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 2/15/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 6/17/2015
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)
Status: Enrolling
Updated: 1/5/2018
VA Connecticut Healthcare System (VACT)
mi
from
West Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
Status: Enrolling
Updated: 11/11/2015
Stanford Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
Status: Enrolling, Phase I
Updated: 12/29/2017
UCLA Medical Center
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Neoplasms Clinical Trial
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Neoplasms Clinical Trial
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Virginia G. Piper Cancer Center Pharmacy
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
New Mexico Oncology Hematology Consultants
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Univ of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Poudre Valley Hospital
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Christus Saint Vincent Regional Cancer Center
mi
from
Santa Fe, NM
Click here to add this to my saved trials